1[1]Fidler IJ.The pathogenesis of cancer metastasis:the 'seed and soil' hypothesis revisited [J].Nat Rev Cancer,2003,3(6):453-458.
2[2]Stacker SA,Achen MG,Jussila L,et al.Lymphangiogenesis and cancer metastasis[J].Nat Rev Cancer,2002,2(8):573-583.
3[3]Stacker SA,Baldwin ME,Achen MG.The role of tumor lymphangiogenesis in metastatic spread[J].FASEB J,2002,16(9):922-934.
4[4]Stacker SA,Achen MG.The vascular endothelial growth factor family:signalling for vascular development [J].Growth Factors,1999,17(1):1-11.
5[5]Carmeliet P,Ferreira V,Breier G,et al.Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele[J].Nature,1996,380(6573):435-439.
6[6]McCarthy M.Antiangiogenesis drug promising for metastatic colorectal cancer[J].Lancet,2003,361(9373):1959.
7[7]Stacker SA,Stenvers K,Caesar C,et al.Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers [J].J Biol Chem,1999,274(45):32127-32136.
8[8]Veikkola T,Jussila L,Makinen T,et al.Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice [J].EMBO J,2001,20(6):1223-1231.
9[9]Cao Y,Linden P,Farnebo J,et al.Vascular endothelial growth factor C induces angiogenesis in vivo[J].Proc Natl Acad Sci USA,1998,95(24):14389-14394.
10[10]Skobe M,Hawighorst T,Jackson DG,et al.Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis[J].Nat Med,2001,7(2):192-198.
2Stacker SA,Achen MG,Jussila L,et al. Lymphangiogenesis and cancer metastasis[J]. Nat Rev Cancer. 2002,2(8):573-583.
3Stacker SA,Baldwin ME,Achen MG. The role of tumor lymphangiogenesis in metastatic spread[J]. FASEB J.2002,16(9):922-934.
4Weidner N. Intratumor microvessel density as a prognostic factor in cancer[J]. Am J Pathol,1995,147(1):9-19.
5White JD,Hewett PW,Kosuge D,et al. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma[J].Cancer Res,2002,62(6): 1669-1675.
6Stacker SA,Achen MG. The vascular endothelial growth factor family: signalling for vascular development[J].Growth Factors,1999,17(1):1-11.
7Veikkola T,Jussila L,Makinen T,et al. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice[J]. EMBO J,2001,20(6): 1223-1231.
8Cao Y,Linden P,Farnebo J,et al. Vascular endothelial growth factor C induces angiogenesis in vivo[J]. Proc Natl Acad Sci USA,1998,95(24):14389-14394.
9Skobe M,Hawighorst T,Jackson DG,et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis[J]. Nat Med,2001,7(2):192-198.
10Joukov V,Sorsa T,Kumar V,et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C[J].EMBO J,1997,16(13):3898-3911.
6Airas J, Niemela J, Salmi M, et al. Differential regulation and function of CD73,a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule,on lymphocytes and endothelial cells[J].Cell Biology,1997,136(2):421-431.
7Moriwaki Y, Yamamoto T, Higashino K. Enzymes involved in purine metabolism-a review of histochemical localization and functional implications [J].Histol Histopathol,1999,14(4):1321-40.
8Rosi F, Carlucci F, Marinello E, et al. Ecto-5'-nucleotidase in B- cell chronic lymphocytic leukemia[J]. Biomed Pharmacother, 2002, 56(2):100-104.
9Thompson LF, Ehzschig HK, Ibla JC, et al. Crucial Role for Ecto- 5' -Nucleotidase (CD73) in vascular leakage during hypoxia[J]. J Exp Med,2004,200(11):1395-1405.
10Blay J, White TD, Hoskin DW. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine[J]. Cancer Res,1997,57(13):2602-2605.
